CD47 and osteosarcoma: The use of a monoclonal antibody against CD47 was not, however, able to entirely eradicate osteosarcoma in a mouse model [410], suggesting that it, like other antibody-based treatments of osteosarcoma, is not sufficient as a monotherapy.